Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026

Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships using intelligence from 1,622 real-world deals.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on 1,622 manufacturing and supply deals across the global life sciences industry.

Manufacturing partnerships are increasingly important as pharmaceutical and biotechnology companies seek specialist capabilities, additional capacity, flexible production, access to new manufacturing technologies and reliable supply throughout development and commercialization.

The report examines how companies establish these relationships, which organizations are particularly active, where dealmaking is concentrated and what can be learned from disclosed financial terms and publicly available contract documents.

Rather than simply identifying transactions, the report helps users understand who is partnering, what manufacturing and supply capabilities are being accessed, how agreements are structured and how responsibilities and commercial obligations are allocated between partners.

It provides a practical intelligence and benchmarking resource for business development, external manufacturing, operations, supply chain, procurement, alliance management, corporate strategy and legal teams evaluating or negotiating manufacturing and supply partnerships.

Understand the manufacturing and supply deal landscape

The report analyzes manufacturing and supply dealmaking from 2021 to 2026, including:

• Trends in dealmaking by year
• Phase of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active manufacturing and supply dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering manufacturing and supply partnerships
• How outsourcing and manufacturing strategies are evolving
• This provides insight into where demand for external manufacturing capabilities is developing and which companies are repeatedly participating in manufacturing and supply partnerships.
• Understand how manufacturing and supply agreements are structured
• Manufacturing and supply relationships require detailed agreement over operational responsibilities, production requirements, quality, pricing and continuity of supply.

The report provides intelligence to help users examine areas including:

• Manufacturing responsibilities
• Production and supply commitments
• Technology transfer
• Scale-up and commercial manufacturing
• Capacity commitments
• Product specifications
• Forecasting and ordering
• Pricing and payment mechanisms
• Minimum purchase or supply obligations
• Quality control and quality assurance
• Regulatory and compliance responsibilities
• Intellectual property and manufacturing know-how
• Exclusivity arrangements
• Geographic or product-specific rights
• Term and termination provisions
• Financial terms where disclosed
• These real-world examples provide useful reference points when establishing or negotiating new manufacturing and supply relationships.
• Identify prospective manufacturing and supply partners
• For companies seeking external manufacturing capabilities, previous transaction activity can provide important intelligence on potential partners.
• The report profiles the Top 25 most active manufacturing and supply dealmakers and provides transaction histories that can help users identify organizations with demonstrated involvement across relevant technologies, product types and stages of development.

This can support:

• CMO and CDMO partner identification
• Manufacturing partner screening
• Outsourcing strategy
• Assessment of specialist capabilities
• Competitor and supplier intelligence
• Business development
• Supply-chain planning
• Deal histories can also help users understand which providers are actively expanding relationships within particular areas of pharmaceutical and biotechnology manufacturing.
• Benchmark leading deals and disclosed financial terms
• The report identifies leading manufacturing and supply transactions by disclosed deal value and provides access to available financial information associated with individual agreements.
• Where disclosed, users can investigate payment structures, investment commitments and other commercial terms to provide additional context when evaluating comparable manufacturing relationships.
• The objective is not simply to establish a headline transaction value, but to understand how real-world manufacturing partnerships have been structured commercially.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying manufacturing and supply contract documents.

These agreements can reveal substantially more detail than company announcements alone, enabling users to examine how selected parties have addressed matters including:

• Production obligations
• Supply commitments
• Pricing and payment
• Forecasting and ordering
• Quality and compliance
• Manufacturing specifications
• Intellectual property
• Exclusivity
• Liability
• Termination
• Continuity of supply
• For teams preparing or negotiating manufacturing agreements, these real-world contracts provide valuable insight into how comparable provisions have been documented in practice.
• Comprehensive manufacturing and supply deal directory
• The report includes a comprehensive directory of 1,622 manufacturing and supply deals, enabling users to identify transactions relevant to their own products, technologies and manufacturing requirements.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and External Partnering teams
• Identify potential manufacturing partners, relevant precedent transactions and companies with demonstrated capabilities.
• External Manufacturing and Operations teams
• Understand how other companies establish manufacturing relationships and allocate operational responsibilities.
• Supply Chain and Procurement teams
• Benchmark supply arrangements and investigate potential providers, commercial structures and contractual obligations.
• Biotechnology Companies Scaling Development
• Identify manufacturing organizations with relevant experience as programs move from development towards clinical and commercial production.
• Corporate and Manufacturing Strategy teams
• Track outsourcing activity and understand how companies are accessing specialist manufacturing technologies, capacity and capabilities.
• Alliance Management teams
• Examine how responsibilities, performance expectations and ongoing obligations have been structured across comparable partnerships.
• Legal and Transaction teams
• Review publicly available agreements and contractual approaches to support drafting, due diligence and negotiation.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying manufacturing and supply intelligence to the customer's own products, technologies, development programs or outsourcing requirements.
• Depending on requirements, this can include relevant comparable deals, prospective manufacturing or supply partners, competitor outsourcing activity, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.